Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT03863717
Other study ID # ????/??/2017/18
Secondary ID
Status Recruiting
Phase N/A
First received
Last updated
Start date December 14, 2017
Est. completion date May 31, 2020

Study information

Verified date January 2020
Source European University Cyprus
Contact Christos Karagiannis
Phone 0035799912547
Email c.karayiannis@euc.ac.cy
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The aim of the study is to investigate the efficacy of upper limb exercise training in Chronic Obstructive Pulmonary Disease (COPD) patients. For the purpose of the study, a controlled trial will be conducted within Respiratory Clinic of Nicosia General Hospital. The sample will be divided in two groups. The intervention group will participate in a pulmonary rehabilitation program which includes upper and lower extremities exercises, with addition of arm ergometer. The second group (control group) will participate in the same program but without arm ergometer training.

The study's hypothesis is that the intervention group will improve the outcome measures significantly better than the control group.


Recruitment information / eligibility

Status Recruiting
Enrollment 44
Est. completion date May 31, 2020
Est. primary completion date May 31, 2020
Accepts healthy volunteers No
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria:

- Diagnosis of COPD confirmed by clinical examination and a pulmonary function test

- Stable clinical condition (without recent respiratory system infections or any exacerbation of the disease)

- Patients must be willing to re evaluate at the end of the study

- Patients must be willing to give written consent for their participation in the study

Exclusion Criteria:

- Age < 18 years old

- Unstable cardiac disease

- Musculoskeletal and neurological diseases that could affect exercise performance or preclude exercise

- Patients of COPD final stage or other serious disease final stage

- Significant cognitive or psychiatric impairment that would lead to an inability to follow simple commands in a group setting

Study Design


Related Conditions & MeSH terms


Intervention

Other:
Arm Endurance Exercise Training
Pulmonary Rehabilitation Program including Upper Limb Endurance Exercise Training with arm cycle ergometer
Control
Pulmonary Rehabilitation Program without Upper Limb Endurance Exercise Training

Locations

Country Name City State
Cyprus Respiratory Clinic, Nicosia General Hospital Nicosia

Sponsors (2)

Lead Sponsor Collaborator
European University Cyprus Nicosia General Hospital

Country where clinical trial is conducted

Cyprus, 

Outcome

Type Measure Description Time frame Safety issue
Primary Upper Limb Muscle Strength, biceps brachii Assess biceps brachii via hand-held dynamometer Micro FET2 Before Intervention
Primary Upper Limb Muscle Strength, biceps brachii Assess biceps brachii via hand-held dynamometer Micro FET2 At 3 months (at the end of intervention)
Primary Upper Limb Muscle Strength, biceps brachii Assess biceps brachii via hand-held dynamometer Micro FET2 Change from Baseline Biceps Brachii Muscle Strength at 3 months
Primary Upper Limb Muscle Strength, triceps Assess triceps via hand-held dynamometer Micro FET2 Before Intervention
Primary Upper Limb Muscle Strength, triceps Assess triceps via hand-held dynamometer Micro FET2 At 3 months (at the end of intervention)
Primary Upper Limb Muscle Strength, triceps Assess triceps via hand-held dynamometer Micro FET2 Change from Baseline Triceps Muscle Strength at 3 months
Primary Upper Limb Muscle Strength, hand-grip Assess via jamar hand dynamometer Before Intervention
Primary Upper Limb Muscle Strength, hand-grip Assess via jamar hand dynamometer At 3 months (at the end of intervention)
Primary Upper Limb Muscle Strength, hand-grip Assess via jamar hand dynamometer Change from Baseline Handgrip Muscle Strength at 3 months
Primary Dyspnea, modified Borg Scale Assess via modified Borg Scale 0 - 10, 0 = no dyspnea, 10 = maximal dyspnea Before Intervention
Primary Dyspnea, modified Borg Scale Assess via modified Borg Scale 0 - 10, 0 = no dyspnea, 10 = maximal dyspnea At 3 months (at the end of intervention)
Primary Dyspnea, modified Borg Scale Assess via modified Borg Scale 0 - 10, 0 = no dyspnea, 10 = maximal dyspnea Change from Baseline Dyspnea at 3 months
Primary Dyspnea, mMRC Scale Assess via modified Medical Research Council Dyspnea Scale 0 - 4, 0 = breathless only with strenuous exercise, 4 = too breathless to leave the house or breathless when dressing Before Intervention
Primary Dyspnea, mMRC Scale Assess via modified Medical Research Council Dyspnea Scale 0 - 4, 0 = breathless only with strenuous exercise, 4 = too breathless to leave the house or breathless when dressing At 3 months (at the end of intervention)
Primary Dyspnea, mMRC Scale Assess via modified Medical Research Council Dyspnea Scale 0 - 4, 0 = breathless only with strenuous exercise, 4 = too breathless to leave the house or breathless when dressing Change from Baseline Dyspnea at 3 months
Primary Fatigue Assess via modified Borg Scale (0 - 10), 0 = no fatigue, 10 = maximal fatigue Before Intervention
Primary Fatigue Assess via modified Borg Scale (0 - 10), 0 = no fatigue, 10 = maximal fatigue At 3 months (at the end of intervention)
Primary Fatigue Assess via modified Borg Scale (0 - 10), 0 = no fatigue, 10 = maximal fatigue Change from Baseline Fatigue at 3 months
Primary Health-related Quality of Life, SGRQ Assess via Saint George Respiratory Questionnaire, A total score incorporates scores from each component of the SGRQ which ranges from 1 to 100, where 0 indicates best health and 100 indicates worst health Before Intervention
Primary Health-related Quality of Life, SGRQ Assess via Saint George Respiratory Questionnaire, A total score incorporates scores from each component of the SGRQ which ranges from 1 to 100, where 0 indicates best health and 100 indicates worst health At 3 months (at the end of intervention)
Primary Health-related Quality of Life, SGRQ Assess via Saint George Respiratory Questionnaire, A total score incorporates scores from each component of the SGRQ which ranges from 1 to 100, where 0 indicates best health and 100 indicates worst health Change from Baseline at 3 months
Primary Health-related Quality of Life, CAT Assess via COPD Assessment Test (CAT), Range of CAT scores from 0-40. Higher scores denote a more severe impact of COPD on a patient's life. Before Intervention
Primary Health-related Quality of Life, CAT Assess via COPD Assessment Test (CAT), Range of CAT scores from 0-40. Higher scores denote a more severe impact of COPD on a patient's life. At 3 months (at the end of intervention)
Primary Health-related Quality of Life, CAT Assess via COPD Assessment Test (CAT), Range of CAT scores from 0-40. Higher scores denote a more severe impact of COPD on a patient's life. Change from Baseline at 3 months
Primary Activities of Daily Living with Upper Limbs Assess via total time need to perform 3 daily activities: (i) simulating of window cleaning, (ii) dry 10 dishes and putting them on a shelf above shoulder level and (iii) putting three packages, each weighing 1000 g, on a shelf above shoulder level Before Intervention
Primary Activities of Daily Living with Upper Limbs Assess via total time need to perform 3 daily activities: (i) simulating of window cleaning, (ii) dry 10 dishes and putting them on a shelf above shoulder level and (iii) putting three packages, each weighing 1000 g, on a shelf above shoulder level At 3 months (at the end of intervention)
Primary Activities of Daily Living with Upper Limbs Assess via total time need to perform 3 daily activities: (i) simulating of window cleaning, (ii) dry 10 dishes and putting them on a shelf above shoulder level and (iii) putting three packages, each weighing 1000 g, on a shelf above shoulder level Change from Baseline time at 3 months
See also
  Status Clinical Trial Phase
Completed NCT05102305 - A Multi-center,Prospective, OS to Evaluate the Effectiveness of 'NAC' Nebulizer Therapy in COPD (NEWEST)
Completed NCT01867762 - An Effectiveness and Safety Study of Inhaled JNJ 49095397 (RV568) in Patients With Moderate to Severe Chronic Obstructive Pulmonary Disease Phase 2
Recruiting NCT05562037 - Stepped Care vs Center-based Cardiopulmonary Rehabilitation for Older Frail Adults Living in Rural MA N/A
Terminated NCT04921332 - Bright Light Therapy for Depression Symptoms in Adults With Cystic Fibrosis (CF) and COPD N/A
Completed NCT03089515 - Small Airway Chronic Obstructive Disease Syndrome Following Exposure to WTC Dust N/A
Completed NCT02787863 - Clinical and Immunological Efficiency of Bacterial Vaccines at Adult Patients With Bronchopulmonary Pathology Phase 4
Recruiting NCT05552833 - Pulmonary Adaptive Responses to HIIT in COPD N/A
Recruiting NCT05835492 - A Pragmatic Real-world Multicentre Observational Research Study to Explore the Clinical and Health Economic Impact of myCOPD
Recruiting NCT05631132 - May Noninvasive Mechanical Ventilation (NIV) and/or Continuous Positive Airway Pressure (CPAP) Increase the Bronchoalveolar Lavage (BAL) Salvage in Patients With Pulmonary Diseases? N/A
Completed NCT03244137 - Effects of Pulmonary Rehabilitation on Cognitive Function in Patients With Severe to Very Severe Chronic Obstructive Pulmonary Disease
Not yet recruiting NCT03282526 - Volume Parameters vs Flow Parameters in Assessment of Reversibility in Chronic Obstructive Pulmonary Disease N/A
Completed NCT02546700 - A Study to Evaluate Safety and Efficacy of Lebrikizumab in Participants With Chronic Obstructive Pulmonary Disease (COPD) Phase 2
Withdrawn NCT04446637 - Acute Bronchodilator Effects of Ipratropium/Levosalbutamol 20/50 mcg Fixed Dose Combination vs Salbutamol 100 mcg Inhaler Plus Ipratropium 20 mcg Inhalation Aerosol Free Combination in Patients With Stable COPD Phase 3
Completed NCT04535986 - A Phase 3 Clinical Trial to Evaluate the Safety and Efficacy of Ensifentrine in Patients With COPD Phase 3
Recruiting NCT05865184 - Evaluation of Home-based Sensor System to Detect Health Decompensation in Elderly Patients With History of CHF or COPD
Completed NCT03256695 - Evaluate the Relationship Between Use of Albuterol Multidose Dry Powder Inhaler With an eModule (eMDPI) and Exacerbations in Participants With Chronic Obstructive Pulmonary Disease (COPD) Phase 3
Completed NCT03295474 - Telemonitoring in Pulmonary Rehabilitation: Feasibility and Acceptability of a Remote Pulse Oxymetry System.
Withdrawn NCT04042168 - Implications of Appropriate Use of Inhalers in Chronic Obstructive Pulmonary Disease (COPD) Phase 4
Completed NCT03414541 - Safety And Efficacy Study Of Orally Administered DS102 In Patients With Chronic Obstructive Pulmonary Disease Phase 2
Completed NCT02552160 - DETECT-Register DocumEnTation and Evaluation of a COPD Combination Therapy